Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136,378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Clinical-radiological-pathological Characteristics of 297 Cases of Surgical Pathology Confirmed Benign Pulmonary Lesions in Which Malignancy Could Not Be Excluded in Preoperative Assessment: A Retrospective Cohort Analysis in a Single Chinese Hospital].
Liu Y, Chen M, Guo C, Zhong W, Ye Q, Zhao J, Zhou Q, Gao X, Liu X, Liang H, Shi Y, Jiang D, Liu H, Xu Y, Li S, Wang M. Liu Y, et al. Among authors: liu x, liu h. Zhongguo Fei Ai Za Zhi. 2020 Sep 20;23(9):792-799. doi: 10.3779/j.issn.1009-3419.2020.104.24. Epub 2020 Aug 10. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32773007 Free PMC article. Chinese.
[Blocking Adenosine/A2AR Pathway for Cancer Therapy].
Liu J, Shi Y, Liu X, Zhang D, Bai Y, Xu Y, Wang M. Liu J, et al. Among authors: liu x. Zhongguo Fei Ai Za Zhi. 2022 Jul 20;25(7):460-467. doi: 10.3779/j.issn.1009-3419.2022.102.24. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35899442 Free PMC article. Review. Chinese.
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China.
Shi Y, Fang J, Zhou C, Liu A, Wang Y, Meng Q, Ding C, Ai B, Gu Y, Yao Y, Sun H, Guo H, Zhang C, Song X, Li J, Xu B, Han Z, Song M, Tang T, Chen P, Lu H, Shui Y, Lou G, Zhang D, Liu J, Liu X, Liu X, Gao X, Zhou Q, Chen M, Zhao J, Zhong W, Xu Y, Wang M. Shi Y, et al. Among authors: liu j, liu x, liu a. Thorac Cancer. 2022 Feb;13(3):412-422. doi: 10.1111/1759-7714.14274. Epub 2021 Dec 21. Thorac Cancer. 2022. PMID: 34935288 Free PMC article.
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments.
Shi Y, Liu X, Liu J, Zhang D, Liu X, Yue Y, Zhou Q, Gao X, Chen M, Xu Y, Zhao J, Zhong W, Provencio M, Jassem J, Williams TM, Seeber A, Kocher F, Wang M. Shi Y, et al. Among authors: liu j, liu x. Transl Lung Cancer Res. 2021 Dec;10(12):4477-4493. doi: 10.21037/tlcr-21-710. Transl Lung Cancer Res. 2021. PMID: 35070755 Free PMC article.
Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study.
Gao X, Chen M, Liu X, Shi Y, Liang H, Zhou Q, Zhao J, Pan R, Zhong W, Xu Y, Wang M. Gao X, et al. Among authors: liu x. Front Oncol. 2022 Apr 26;12:879554. doi: 10.3389/fonc.2022.879554. eCollection 2022. Front Oncol. 2022. PMID: 35558520 Free PMC article.
Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study.
Zhang D, Shi Y, Liu X, Liu J, Xu Y, Zhao J, Zhong W, Käsmann L, Hakozaki T, Provencio M, Horita N, Fukuda N, Chen M, Wang M. Zhang D, et al. Among authors: liu j, liu x. Transl Lung Cancer Res. 2022 Jul;11(7):1420-1433. doi: 10.21037/tlcr-22-464. Transl Lung Cancer Res. 2022. PMID: 35958331 Free PMC article.
136,378 results
You have reached the last available page of results. Please see the User Guide for more information.